Everest Medicines Announces NEFECON® Has Received Full Approval from South Korea’s Ministry of Food and Drug Safety (MFDS) for the Treatment of Primary IgA Nephropathy
SHANGHAI, Nov. 19, 2024 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that NEFECON
Machine Translation Market to Grow by USD 1.23 Billion (2024-2028), Driven by Content Localization Demand, with AI Redefining Market Landscape – Technavio
NEW YORK, Nov. 18, 2024 /PRNewswire/ — Report with market evolution powered by AI – The global machine translation market size is estimated to grow by USD 1.23 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 15.89% during the forecast p
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Lilium N.V. – LILM
NEW YORK, Nov. 18, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Lilium N.V. (“Lilium” or the “Company”) (NASDAQ: LILM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Evolv Technologies Holdings, Inc. – EVLV
NEW YORK, Nov. 18, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Evolv Technologies Holdings, Inc. (“Evolv” or the “Company”) (NASDAQ: EVLV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.co
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against WM Technology, Inc. – MAPS
NEW YORK, Nov. 18, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against WM Technology, Inc. (“WM” or the “Company”) (NASDAQ: MAPS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980,
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Hasbro, Inc. – HAS
NEW YORK, Nov. 18, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Hasbro, Inc. (“Hasbro” or the “Company”) (NASDAQ: HAS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against PACS Group, Inc. – PACS
NEW YORK, Nov. 18, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against PACS Group, Inc. (“PACS” or the “Company”) (NYSE: PACS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (o
BIOVAXYS ANNOUNCES PRIVATE PLACEMENT OFFERING
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, Nov. 18, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (“BioVaxys” or the “Company“) is pleased to announce that it intends to c
Treasury Board President Anita Anand tables the Supplementary Estimates (B), 2024-25
OTTAWA, ON, Nov. 18, 2024 /CNW/ – Each year, the President of the Treasury Board tables Main Estimates and Supplementary Estimates, outlining proposed government spending to fund the programs and services that Canadians rely on. Today, the Honourable Anita Anand, President of the Treasury Boar
OUR Rescue Supports Argentina’s Largest Operation Targeting Online Child Exploitation Networks
Multi-city, Multi-agency effort leads to 116 arrests and 70 survivors identified SALT LAKE CITY, Nov. 18, 2024 /PRNewswire/ — On Nov. 12, 2024, the Buenos Aires Public Prosecutor’s Office, OUR Rescue and several other international law enforcement agencies and nonprofit organizations car
